Does anyone know what would happen if you antagonise and agonise a receptor at the same time ?
I am not sure of an exact answer -
@D4n, but I'm sure a lot of people do this by accident without even considering it. When they take something to counteract side effects, or to restore sensitivity, or prevent Excitotoxicity. It could be more beneficial in certain cases. I'm not talking about PFS, but more about "drugs"/dopamine, serotonin, norepinephrine. PFS etc affects so so many different things in seemingly very confusing ways.
Maybe also, neurotoxicity or excitotoxicity occurs depending which side "wins".
People who use drugs, do this all the time and then reuptake with smoking, preventing clearing of the synapses. After say X, MDMA, COKE, AMPS, etc.
People who use uppers and downers (that's a bad idea), or alcohol, or any number of things for "come downs".
(-BY the way lots of words, I use are shown as spelling errors when in fact they are spelled correctly. BUT* that would happen on near all word editors too -No big deal) .
Like Excitotoxicity above.
-Went to banff. It was ok most part.
Here's an OLD study, from 1992:
Concurrent agonist-antagonist administration for the analysis and treatment of drug dependence.
Rose JE1, Levin ED.
Author information
Abstract
"Two key strategies for the treatment of drug dependence involve the use of agonists to substitute for the abused drug and the use of antagonists to block the reinforcing actions maintaining drug self-administration. A different strategy for the treatment of drug dependence is outlined, comprising the concurrent administration of an agonist and an antagonist. Concurrent administration of an agonist with an antagonist, in the proper ratio, should produce maximal occupancy of receptors and attenuation of the reinforcing actions of the abused drug. The addict would be relatively "insulated" from the reinforcing effects of the abused drug; at the same time the balance of agonist and antagonist effects is predicted to prevent withdrawal symptoms or intoxication resulting from an under- or over-stimulation of drug receptors. Advantages over the use of agonists alone and antagonists alone, and over mixed agonist-antagonist molecules, are discussed. Application of concurrent agonist-antagonist administration to the analysis of mechanisms underlying nondrug reinforcement and to the treatment of disorders involving receptor disregulation is also described."